Astellas Pharma
Carbon footprint
Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Astellas Pharma reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 March 2021 at 123 Kt (-44 /-26.2% y-o-y). Also positively, carbon intensity was down at 14 t (-1.6 /-10.1% y-o-y).
No public disclosure of Scope 3 emissions has been found for Astellas Pharma at the moment.
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.
Astellas Pharma also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Astellas Pharma Inc. commits to reduce absolute scope 1 and 2 GHG emissions 63% by FY2030 from a FY2015 base year. Astellas Pharma Inc.commits to reduce absolute scope 3 GHG missions 37.5% by FY2030 from a FY2015 base year.